Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Asset Utilization Ratio (2016 - 2025)

Northwest Biotherapeutics' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.02 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.02 for Q4 2025, down 50.06% from a year ago — trailing twelve months through Dec 2025 was 0.02 (down 50.06% YoY), and the annual figure for FY2025 was 0.03, down 49.61%.
  • Asset Utilization Ratio for Q4 2025 was 0.02 at Northwest Biotherapeutics, down from 0.03 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.07 in Q3 2023 to a low of 0.02 in Q4 2025.
  • The 5-year median for Asset Utilization Ratio is 0.05 (2024), against an average of 0.05.
  • The sharpest move saw Asset Utilization Ratio plummeted 88.97% in 2021, then surged 103.84% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2021, then soared by 83.45% to 0.05 in 2022, then grew by 20.72% to 0.07 in 2023, then decreased by 24.25% to 0.05 in 2024, then plummeted by 50.06% to 0.02 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.02, 0.03, and 0.04 for Q4 2025, Q3 2025, and Q2 2025 respectively.